Ovarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in the U.S. die from the disease every year.

Ovarian cancer and irritable bowel syndrome (IBS) can present with similar symptoms, making it challenging to distinguish between them. Both conditions may cause abdominal discomfort, bloating, and ...

One of the main challenges when it comes to effective diagnosis and treatment for ovarian cancer is the complexity of identifying symptoms. This is largely due to the fact that most ovarian cancer ...

SEATTLE — The typical symptoms of ovarian cancer can deceptively be passed off as "normal" leading to it being found in its later stages. It's why doctors and survivors urge women to know the warning ...

Jenny Doust does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

DENVER — Thursday will be recognized as "Wear Teal Day" in Colorado. In Colorado, 330 women are diagnosed with ovarian cancer each year — approximately one Colorado woman every day. Knowing the ...

MEDICAL CENTER. IT USED TO BE THOUGHT THAT OVARIAN CANCER HAD NO REAL NOTICEABLE SYMPTOMS, BUT THERE ARE CERTAIN RED FLAGS THAT DOCTORS SAY YOU SHOULD WATCH OUT FOR. MERCY MEDICAL CENTER DOCTOR BEAMAN ...

This informational guide, part of POPSUGAR's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to ...

Ovarian cancer can be hard to diagnose. Doctors say women need to pay attention to their bodies and report any symptoms that have been persistent for more than three weeks. “The problem with ovarian ...

"I blacked out for most of the conversation," Emma Schlamm said of the moment she learned she had ovarian cancer Ingrid Vasquez is a Digital News Writer at PEOPLE. She graduated from The University of ...

Exercise improves quality of life and sleep in ovarian cancer patients, with moderate and significant benefits, respectively. Methodological variability and high heterogeneity in trials highlight the ...